<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00468637</url>
  </required_header>
  <id_info>
    <org_study_id>133/04</org_study_id>
    <nct_id>NCT00468637</nct_id>
  </id_info>
  <brief_title>Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe</brief_title>
  <acronym>AMORE-Eur</acronym>
  <official_title>Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Saarland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the influence of cardiovascular risk factors, heart
      failure and cardiovascular drug therapy on erectile function in cardiovascular high-risk
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Association of cardiovascular risk factors and ED is likely due to an impairment of
      endothelial function resulting in a decreased activity of endothelial NO-synthase, which
      plays a major role in physiology of erection. Heart failure is also known to further
      contribute to endothelial dysfunction and hence, this could lead to erectile dysfunction.

      Study Objectives

        1. Evaluation of the influence of cardiovascular risk factors and concomitant medication on
           erectile function in cardiovascular high-risk patients.

        2. Evaluation of the role of heart failure on prevalence and severity of erectile
           dysfunction in men.

        3. Long-term effects of cardiovascular drug therapy and cardiovascular diseases on erectile
           function.

      Study Design Male patients across Europe with cardiovascular diseases (CHD, PAD and heart
      failure) will be evaluated with a standardized questionnaire. Grade of erectile dysfunction
      will be assessed using an ED-score, generated from two different questionnaires.

        1. IIEF-5 - (International Index of Erectile Function)

        2. KEED - (Cologne Evaluation of Erectile Dysfunction)

      Primary Endpoint The primary endpoint is the sum score of the ED rating scale of the KEED
      (Kölner Erhebungsbogen zur Erektilen Dysfunktion, see Appendix 1). Erectile dysfunction is
      defined as reaching more than 17 points in the sum score.

      Secondary Endpoint The first secondary endpoint is the frequency of sexual activity and
      sexual desire. Another secondary endpoint contains satisfaction with sex life and general
      well-being. Men are defined as dissatisfied by answering &quot;mixed&quot; or &quot;worse&quot;.

      Follow-Up: after 1 year, after 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Cardiovascular High-Risk</condition>
  <condition>Chronic Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic, outpatient department, general practitioner
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients with two or more cardiovascular risk factors or

          -  Male patients with a manifestation of atherosclerosis or

          -  Male patients with an ischemic or dilated cardiomyopathy

          -  Written informed consent

        Exclusion Criteria:

          -  Impairment of hormonal status

          -  Refusal of written informed consent

          -  Inability to complete the questionnaires
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Böhm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, University Hospital of the Saarland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magnus Baumhäkel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, University Hospital of the Saarland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Böhm, MD</last_name>
    <phone>0049-6841-16-</phone>
    <phone_ext>23000</phone_ext>
    <email>michael.boehm@uniklinikum-saarland.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magnus Baumhäkel, MD</last_name>
    <phone>0049-6841-16-</phone>
    <phone_ext>23000</phone_ext>
    <email>magnus@baumhaekel.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiology, University Hospital of the Saarland</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magnus Baumhäkel, MD</last_name>
      <phone>0049-6841-16</phone>
      <phone_ext>23000</phone_ext>
      <email>magnus@baumhaekel.de</email>
    </contact>
    <investigator>
      <last_name>Magnus Baumhäkel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mario Kratz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis &amp; Ambulante Tagesklinik</name>
      <address>
        <city>Merzig-Schwemlingen</city>
        <state>Saarland</state>
        <zip>66663</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Rettig-Ewen, MD</last_name>
      <phone>0049-6861</phone>
      <phone_ext>992902</phone_ext>
      <email>praxis@rettig-ewen.de</email>
    </contact>
    <investigator>
      <last_name>Volker Rettig-Ewen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Section on Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Saporetti, MD</last_name>
      <email>alberto@funkgogh.it</email>
    </contact>
    <contact_backup>
      <last_name>Marco Metra, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Alberto Saporetti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Metra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, 4th Military Clinical Hospital</name>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewa A Jankowska, MD</last_name>
      <email>ewa@antro.pan.wroc.pl</email>
    </contact>
    <contact_backup>
      <last_name>Piotr Ponikowski, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ewa A Jankowska, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotr Ponikowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999 Dec;11(6):319-26.</citation>
    <PMID>10637462</PMID>
  </reference>
  <reference>
    <citation>Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000 Dec;12(6):305-11.</citation>
    <PMID>11416833</PMID>
  </reference>
  <reference>
    <citation>Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R, Maggi M. Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res. 2003 Jun;15(3):210-20.</citation>
    <PMID>12904808</PMID>
  </reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2007</study_first_submitted>
  <study_first_submitted_qc>May 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2007</study_first_posted>
  <last_update_submitted>February 13, 2009</last_update_submitted>
  <last_update_submitted_qc>February 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Magnus Baumhäkel</name_title>
    <organization>Department of Cardiology, University Hospital of the Saarland</organization>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>cardiovascular high risk</keyword>
  <keyword>erectile dysfunction</keyword>
  <keyword>cardiovascular disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

